Understanding GLP-1 Receptor Agonists in Research
The landscape of GLP-1 Receptor Agonist">GLP-1 receptor agonist research has expanded dramatically since the early discovery of incretin-based pathways. Peptides that target the glucagon-like peptide-1 receptor have demonstrated broad metabolic effects, making them one of the most actively studied classes in modern pharmaceutical science. At PeptaCo, we supply high-purity GLP-1 raw materials for research, analytical, and formulation-development applications, including Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide.
GLP-1 receptor agonists originated as glucose-lowering agents, but their therapeutic potential now encompasses multiple metabolic pathways. The second generation of these peptides targets additional incretin receptors and energy-balance circuits, enabling single-molecule approaches to metabolic modulation that were previously achievable only through combination therapy.
Semaglutide: The GLP-1 Receptor Agonist">GLP-1 Receptor Agonist
Semaglutide is a glucagon-like peptide-1 receptor agonist featuring a single fatty acid side chain that enables albumin binding and extends the peptide half-life. With molecular formula C246H385N65O75 and molecular weight 4113.73 Da, Semaglutide is a 39-amino-acid peptide analog of native GLP-1 (7-37).
In research settings, Semaglutide has been extensively evaluated for its metabolic effects, including glucose-dependent insulin secretion, appetite modulation, and energy homeostasis. The extended half-life enabled by the albumin-binding fatty acid chain allows less frequent dosing in preclinical and clinical studies compared to native GLP-1.
PeptaCo offers Semaglutide in multiple specifications (5mg, 10mg, 15mg, 20mg, 40mg) to accommodate different research needs. Learn more about Semaglutide, Semaglutide 10mg, Semaglutide 15mg, Semaglutide 20mg, and Semaglutide 40mg.
Tirzepatide: Dual GIP/GLP-1 Receptor Agonist
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist, meaning it activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptors simultaneously. This dual-mechanism approach has demonstrated enhanced metabolic effects compared to selective GLP-1 receptor agonists alone. Tirzepatide comprises 39 amino acids with a molecular weight of 4418.48 Da.
The GIP receptor co-agonism adds a distinct metabolic dimension: GIP receptor signaling contributes to lipid metabolism modulation, adipose tissue remodeling, and potentially improved lipid profiles, complementing the glucose-lowering and appetite-regulating effects of GLP-1 receptor activation. This makes Tirzepatide one of the most potent metabolic modulators in current peptide research.
Available specifications include Tirzepatide 5mg, Tirzepatide 10mg, Tirzepatide 15mg, Tirzepatide 20mg, Tirzepatide 30mg, and Tirzepatide 60mg.
Retatrutide: Triple Agonist in Peptide Research
Retatrutide represents a third-generation approach to metabolic research, co-activating three incretin receptors: GLP-1, GIP, and glucagon receptors (GCGR). This triple-agonist design targets the full spectrum of incretin-mediated metabolic pathways in a single molecule, offering a potentially broader therapeutic window than dual-agonist compounds.
With a unique amino acid sequence and structural modifications that confer extended half-life, Retatrutide has attracted significant research interest. The glucagon receptor component adds energy expenditure modulation to the metabolic effects of GLP-1 and GIP co-activation, potentially enabling a more comprehensive approach to metabolic pathway regulation.
PeptaCo supplies Retatrutide in specifications ranging from Retatrutide 5mg to Retatrutide 60mg in six available strengths (5mg, 10mg, 15mg, 20mg, 30mg, 60mg), allowing researchers to select the specification best suited for their study design.
Cagrilintide: The Amylin Analogue
Cagrilintide is a long-acting amylin analog comprising a 11-amino-acid sequence with structural modifications that confer extended half-life through albumin binding. With molecular formula C113H173N27O30 and molecular weight 2357.80 Da, Cagrilintide targets the amylin receptor complex (CRLR/RAMP1/RAMP2/RAMP3).
Amylin co-secreted with insulin from pancreatic beta cells plays a role in satiety signaling and glucose regulation. Cagrilintide prolongs gastric emptying, reduces appetite, and modulates postprandial glucose excursion. In combination therapy research, Cagrilintide has been investigated alongside GLP-1 receptor agonists for their complementary metabolic effects, making it an important addition to the metabolic research toolkit.
Available at PeptaCo: Cagrilintide 5mg.
GLP-1 Peptide Comparison
| Parameter | Semaglutide | Tirzepatide | Retatrutide | Cagrilintide |
|---|---|---|---|---|
| Receptor Targets | GLP-1 | GIP + GLP-1 | GLP-1 + GIP + GCGR | Amylin |
| Amino Acids | 39 | 39 | 37 | 11 |
| Molecular Weight (Da) | 4113.73 | 4418.48 | 4122.75 | 2357.80 |
| Available Specs | 5, 10, 15, 20, 40 mg | 5, 10, 15, 20, 30, 60 mg | 5, 10, 15, 20, 30, 60 mg | 5 mg |
| Half-Life Extension | Fatty acid chain | Fatty acid chain | Fatty acid chain | Albumin binding |
Storage and Handling Recommendations
All GLP-1 peptides supplied by PeptaCo should be stored according to standard peptide handling protocols. Lyophilized material should be kept at -20°C or below, protected from light and moisture. Once reconstituted, solutions should be aliquoted and stored at 4°C for short-term use or -80°C for long-term storage, avoiding repeated freeze-thaw cycles.
For detailed handling protocols, see our Semaglutide product page and Tirzepatide product page, which include batch-specific COA documentation and analytical verification data.
Conclusion
The GLP-1 receptor agonist class, including its expanding derivatives and combination targets, represents one of the most dynamic areas of peptide research. From selective GLP-1 agonists to dual and triple receptor co-activators, these molecules offer researchers increasingly sophisticated tools for metabolic pathway investigation. PeptaCo provides a comprehensive range of GLP-1 raw materials in multiple specifications to support research at every stage.
All products are supplied for qualified research, analytical, and formulation-development applications. Not intended for direct human or veterinary use.
